Mamawi, Rodri Evan S.

HRN: 27-43-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/10/2026
02/16/2026
IV
285mg
Q6H
PCAP-C With HRAD
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines